This pipeline computes the correlation between significant copy number variation (cnv) genes and selected clinical features.
Testing the association between copy number variation of 88 peak regions and 5 clinical features across 410 patients, 115 significant findings detected with Q value < 0.25.
-
Amp Peak 1(1p34.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 3(1q21.3) cnvs correlated to 'AGE'.
-
Amp Peak 4(1q22) cnvs correlated to 'AGE'.
-
Amp Peak 5(2p23.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 6(2q13) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 7(3p25.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 8(3q26.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 9(3q26.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 10(4p16.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 11(5p15.33) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 12(6p24.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 16(8p11.21) cnvs correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 17(8q24.21) cnvs correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 18(8q24.21) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 19(9p24.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 20(9q34.3) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 22(11p11.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 23(11q13.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 24(11q22.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 27(12q13.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 28(14q24.3) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 29(14q32.33) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 31(16p11.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 32(17p11.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 33(17q11.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 34(17q12) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 35(17q21.32) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 36(18q11.2) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 37(19p13.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 38(19p13.13) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 39(19q12) cnvs correlated to 'AGE', 'HISTOLOGICAL.TYPE', and 'NEOADJUVANT.THERAPY'.
-
Amp Peak 40(20p13) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 41(20q11.21) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 42(20q13.12) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 43(20q13.33) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 1(1p36.31) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 2(1p36.11) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 3(2q22.1) cnvs correlated to 'Time to Death'.
-
Del Peak 5(3p14.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 6(4p16.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 7(4q22.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 8(4q34.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 9(5q11.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 11(7p22.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 12(7q11.22) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 13(7q36.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 14(8p23.3) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 15(8p11.22) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 16(9p23) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 17(9q34.11) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 20(11p15.5) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 21(11q14.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 22(11q24.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 24(12q24.33) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 25(13q11) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 27(14q13.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 28(15q15.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 29(15q23) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 30(16p13.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 31(16q22.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 32(16q23.1) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 33(17p13.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 34(17p11.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 35(17p11.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 36(17q11.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 37(17q21.2) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 38(18q23) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 39(19p13.3) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 40(19q13.43) cnvs correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 45(22q13.32) cnvs correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
Table 1. Get Full Table Overview of the association between significant copy number variation of 88 regions and 5 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 115 significant findings detected.
Clinical Features |
Time to Death |
AGE |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
NEOADJUVANT THERAPY |
||
nCNV (%) | nWild-Type | logrank test | t-test | Chi-square test | Fisher's exact test | Fisher's exact test | |
Amp Peak 39(19q12) | 49 (12%) | 361 |
0.0233 (1.00) |
8.84e-07 (0.000334) |
6.08e-24 (2.67e-21) |
0.514 (1.00) |
3.68e-05 (0.013) |
Amp Peak 7(3p25 1) | 48 (12%) | 362 |
0.321 (1.00) |
0.000573 (0.189) |
3.33e-07 (0.000127) |
0.324 (1.00) |
0.377 (1.00) |
Amp Peak 8(3q26 2) | 100 (24%) | 310 |
0.212 (1.00) |
1.47e-07 (5.67e-05) |
2.64e-18 (1.14e-15) |
0.109 (1.00) |
0.0252 (1.00) |
Amp Peak 9(3q26 2) | 95 (23%) | 315 |
0.05 (1.00) |
3.75e-05 (0.0132) |
7.9e-19 (3.41e-16) |
0.132 (1.00) |
0.0798 (1.00) |
Amp Peak 10(4p16 3) | 27 (7%) | 383 |
0.895 (1.00) |
6.99e-06 (0.00254) |
2.53e-13 (1.07e-10) |
0.531 (1.00) |
0.0364 (1.00) |
Amp Peak 12(6p24 2) | 58 (14%) | 352 |
0.949 (1.00) |
0.000327 (0.111) |
1.53e-10 (6.26e-08) |
0.761 (1.00) |
0.328 (1.00) |
Amp Peak 16(8p11 21) | 98 (24%) | 312 |
4.98e-06 (0.00182) |
0.941 (1.00) |
0.000563 (0.186) |
0.321 (1.00) |
0.184 (1.00) |
Amp Peak 17(8q24 21) | 125 (30%) | 285 |
0.000637 (0.208) |
0.146 (1.00) |
1.2e-08 (4.75e-06) |
0.421 (1.00) |
0.00135 (0.427) |
Amp Peak 22(11p11 2) | 23 (6%) | 387 |
0.384 (1.00) |
0.000598 (0.197) |
3.37e-08 (1.31e-05) |
1 (1.00) |
0.139 (1.00) |
Amp Peak 34(17q12) | 46 (11%) | 364 |
0.0319 (1.00) |
4.53e-05 (0.0159) |
1.44e-15 (6.11e-13) |
0.502 (1.00) |
0.00183 (0.57) |
Amp Peak 35(17q21 32) | 36 (9%) | 374 |
0.013 (1.00) |
2.52e-05 (0.00902) |
3.74e-06 (0.00138) |
0.578 (1.00) |
0.158 (1.00) |
Amp Peak 37(19p13 2) | 49 (12%) | 361 |
0.799 (1.00) |
2.3e-10 (9.32e-08) |
8.1e-16 (3.45e-13) |
0.073 (1.00) |
0.727 (1.00) |
Amp Peak 38(19p13 13) | 53 (13%) | 357 |
0.594 (1.00) |
4.88e-11 (2.01e-08) |
3.46e-19 (1.5e-16) |
0.155 (1.00) |
0.239 (1.00) |
Amp Peak 41(20q11 21) | 65 (16%) | 345 |
0.904 (1.00) |
0.000187 (0.0639) |
7.37e-20 (3.2e-17) |
0.471 (1.00) |
0.0287 (1.00) |
Amp Peak 42(20q13 12) | 67 (16%) | 343 |
0.101 (1.00) |
7.44e-05 (0.0259) |
3.15e-18 (1.35e-15) |
0.152 (1.00) |
0.0205 (1.00) |
Amp Peak 43(20q13 33) | 68 (17%) | 342 |
0.452 (1.00) |
0.000195 (0.0665) |
1.95e-11 (8.06e-09) |
0.118 (1.00) |
0.0221 (1.00) |
Del Peak 2(1p36 11) | 46 (11%) | 364 |
0.15 (1.00) |
0.000629 (0.206) |
5.65e-10 (2.27e-07) |
0.868 (1.00) |
0.28 (1.00) |
Del Peak 5(3p14 2) | 40 (10%) | 370 |
0.425 (1.00) |
2.97e-05 (0.0106) |
4.56e-10 (1.84e-07) |
0.86 (1.00) |
0.179 (1.00) |
Del Peak 6(4p16 3) | 45 (11%) | 365 |
0.125 (1.00) |
0.000132 (0.0454) |
3.8e-11 (1.56e-08) |
0.499 (1.00) |
0.366 (1.00) |
Del Peak 7(4q22 1) | 46 (11%) | 364 |
0.029 (1.00) |
0.000763 (0.249) |
1.18e-12 (4.96e-10) |
0.132 (1.00) |
0.28 (1.00) |
Del Peak 8(4q34 3) | 63 (15%) | 347 |
0.269 (1.00) |
6.48e-05 (0.0227) |
3.04e-17 (1.3e-14) |
0.561 (1.00) |
0.00703 (1.00) |
Del Peak 9(5q11 2) | 53 (13%) | 357 |
0.458 (1.00) |
7.98e-05 (0.0277) |
1.13e-21 (4.91e-19) |
1 (1.00) |
0.0169 (1.00) |
Del Peak 11(7p22 3) | 44 (11%) | 366 |
0.0426 (1.00) |
0.000118 (0.0408) |
2.65e-10 (1.07e-07) |
1 (1.00) |
0.0427 (1.00) |
Del Peak 13(7q36 1) | 40 (10%) | 370 |
0.203 (1.00) |
1.15e-06 (0.00043) |
6.81e-20 (2.96e-17) |
0.476 (1.00) |
0.00173 (0.546) |
Del Peak 16(9p23) | 36 (9%) | 374 |
0.439 (1.00) |
0.000322 (0.109) |
2.95e-08 (1.15e-05) |
0.709 (1.00) |
0.0692 (1.00) |
Del Peak 17(9q34 11) | 75 (18%) | 335 |
0.464 (1.00) |
2.51e-08 (9.85e-06) |
1.51e-10 (6.2e-08) |
0.681 (1.00) |
0.027 (1.00) |
Del Peak 20(11p15 5) | 54 (13%) | 356 |
0.0134 (1.00) |
2.26e-06 (0.000836) |
2.63e-12 (1.1e-09) |
0.35 (1.00) |
0.00381 (1.00) |
Del Peak 21(11q14 1) | 38 (9%) | 372 |
0.00766 (1.00) |
0.00034 (0.115) |
1.63e-08 (6.44e-06) |
0.472 (1.00) |
0.116 (1.00) |
Del Peak 22(11q24 2) | 48 (12%) | 362 |
0.00236 (0.728) |
7.03e-05 (0.0245) |
7.84e-09 (3.13e-06) |
0.512 (1.00) |
0.0513 (1.00) |
Del Peak 24(12q24 33) | 26 (6%) | 384 |
0.496 (1.00) |
0.000398 (0.133) |
3.81e-06 (0.0014) |
0.389 (1.00) |
0.253 (1.00) |
Del Peak 25(13q11) | 43 (10%) | 367 |
0.305 (1.00) |
0.000346 (0.116) |
2e-06 (0.000744) |
0.391 (1.00) |
0.46 (1.00) |
Del Peak 27(14q13 1) | 34 (8%) | 376 |
0.00966 (1.00) |
3.65e-05 (0.0129) |
6.3e-07 (0.000239) |
1 (1.00) |
0.038 (1.00) |
Del Peak 28(15q15 1) | 73 (18%) | 337 |
0.198 (1.00) |
1.26e-06 (0.000472) |
1.73e-10 (7.05e-08) |
0.167 (1.00) |
0.0741 (1.00) |
Del Peak 29(15q23) | 57 (14%) | 353 |
0.108 (1.00) |
5.07e-06 (0.00185) |
1.91e-11 (7.91e-09) |
0.544 (1.00) |
0.0732 (1.00) |
Del Peak 30(16p13 3) | 43 (10%) | 367 |
0.00398 (1.00) |
9.23e-07 (0.000347) |
4.01e-07 (0.000153) |
0.391 (1.00) |
0.854 (1.00) |
Del Peak 31(16q22 3) | 95 (23%) | 315 |
0.169 (1.00) |
8.7e-08 (3.37e-05) |
3.46e-16 (1.48e-13) |
0.616 (1.00) |
0.0431 (1.00) |
Del Peak 32(16q23 1) | 100 (24%) | 310 |
0.133 (1.00) |
1.27e-08 (5.02e-06) |
3.62e-19 (1.56e-16) |
0.538 (1.00) |
0.00343 (1.00) |
Del Peak 33(17p13 3) | 61 (15%) | 349 |
0.201 (1.00) |
2.14e-05 (0.00768) |
1.17e-11 (4.87e-09) |
0.552 (1.00) |
0.00382 (1.00) |
Del Peak 34(17p11 2) | 71 (17%) | 339 |
0.135 (1.00) |
4.2e-07 (0.000159) |
2.8e-22 (1.23e-19) |
0.33 (1.00) |
0.00415 (1.00) |
Del Peak 35(17p11 2) | 64 (16%) | 346 |
0.43 (1.00) |
2.37e-06 (0.000873) |
3.33e-14 (1.41e-11) |
1 (1.00) |
0.0851 (1.00) |
Del Peak 36(17q11 2) | 60 (15%) | 350 |
0.938 (1.00) |
1.28e-05 (0.0046) |
3.19e-09 (1.28e-06) |
0.372 (1.00) |
0.148 (1.00) |
Del Peak 37(17q21 2) | 61 (15%) | 349 |
0.58 (1.00) |
5.37e-06 (0.00196) |
2.87e-10 (1.16e-07) |
0.234 (1.00) |
0.0544 (1.00) |
Del Peak 39(19p13 3) | 95 (23%) | 315 |
0.0346 (1.00) |
3.14e-13 (1.32e-10) |
2.86e-42 (1.26e-39) |
0.452 (1.00) |
0.00193 (0.6) |
Del Peak 45(22q13 32) | 79 (19%) | 331 |
0.0572 (1.00) |
1.84e-07 (7.08e-05) |
2.43e-13 (1.03e-10) |
0.422 (1.00) |
0.0605 (1.00) |
Amp Peak 1(1p34 2) | 26 (6%) | 384 |
0.843 (1.00) |
0.00103 (0.331) |
1.09e-08 (4.33e-06) |
1 (1.00) |
0.159 (1.00) |
Amp Peak 3(1q21 3) | 160 (39%) | 250 |
0.308 (1.00) |
0.000375 (0.126) |
0.044 (1.00) |
1 (1.00) |
0.729 (1.00) |
Amp Peak 4(1q22) | 170 (41%) | 240 |
0.0594 (1.00) |
3.1e-05 (0.011) |
0.0159 (1.00) |
1 (1.00) |
0.647 (1.00) |
Amp Peak 5(2p23 2) | 72 (18%) | 338 |
0.0574 (1.00) |
0.00345 (1.00) |
2.63e-07 (0.000101) |
0.0526 (1.00) |
0.456 (1.00) |
Amp Peak 6(2q13) | 66 (16%) | 344 |
0.072 (1.00) |
0.00124 (0.393) |
4.69e-08 (1.82e-05) |
0.775 (1.00) |
0.0636 (1.00) |
Amp Peak 11(5p15 33) | 48 (12%) | 362 |
0.0179 (1.00) |
0.00979 (1.00) |
6.55e-12 (2.72e-09) |
1 (1.00) |
0.216 (1.00) |
Amp Peak 18(8q24 21) | 132 (32%) | 278 |
0.00681 (1.00) |
0.0488 (1.00) |
1.22e-09 (4.91e-07) |
0.175 (1.00) |
0.00732 (1.00) |
Amp Peak 19(9p24 2) | 33 (8%) | 377 |
0.534 (1.00) |
0.0808 (1.00) |
7.7e-06 (0.00279) |
0.242 (1.00) |
0.145 (1.00) |
Amp Peak 20(9q34 3) | 20 (5%) | 390 |
0.00311 (0.939) |
0.00111 (0.354) |
9.12e-07 (0.000344) |
1 (1.00) |
0.0607 (1.00) |
Amp Peak 23(11q13 2) | 33 (8%) | 377 |
0.219 (1.00) |
0.208 (1.00) |
0.000101 (0.0348) |
0.848 (1.00) |
0.0108 (1.00) |
Amp Peak 24(11q22 2) | 24 (6%) | 386 |
0.145 (1.00) |
0.001 (0.323) |
9.74e-05 (0.0337) |
0.174 (1.00) |
0.0272 (1.00) |
Amp Peak 27(12q13 2) | 50 (12%) | 360 |
0.512 (1.00) |
0.157 (1.00) |
9.11e-06 (0.00329) |
0.419 (1.00) |
0.729 (1.00) |
Amp Peak 28(14q24 3) | 30 (7%) | 380 |
0.772 (1.00) |
0.0134 (1.00) |
3.57e-07 (0.000137) |
0.16 (1.00) |
0.0786 (1.00) |
Amp Peak 29(14q32 33) | 31 (8%) | 379 |
0.119 (1.00) |
0.0303 (1.00) |
1.51e-06 (0.000563) |
0.317 (1.00) |
0.0868 (1.00) |
Amp Peak 31(16p11 2) | 33 (8%) | 377 |
0.195 (1.00) |
0.00147 (0.465) |
1.63e-14 (6.93e-12) |
0.337 (1.00) |
0.00291 (0.886) |
Amp Peak 32(17p11 2) | 14 (3%) | 396 |
0.414 (1.00) |
0.486 (1.00) |
0.000398 (0.133) |
0.39 (1.00) |
0.0539 (1.00) |
Amp Peak 33(17q11 2) | 36 (9%) | 374 |
0.0143 (1.00) |
0.0031 (0.939) |
6.25e-11 (2.56e-08) |
0.261 (1.00) |
0.158 (1.00) |
Amp Peak 36(18q11 2) | 32 (8%) | 378 |
0.0135 (1.00) |
0.00122 (0.388) |
2.49e-08 (9.78e-06) |
0.435 (1.00) |
0.833 (1.00) |
Amp Peak 40(20p13) | 50 (12%) | 360 |
0.171 (1.00) |
0.0133 (1.00) |
2.24e-06 (0.000832) |
0.144 (1.00) |
0.0819 (1.00) |
Del Peak 1(1p36 31) | 40 (10%) | 370 |
0.368 (1.00) |
0.00233 (0.721) |
0.000403 (0.134) |
0.476 (1.00) |
0.179 (1.00) |
Del Peak 3(2q22 1) | 26 (6%) | 384 |
3.39e-05 (0.012) |
0.0308 (1.00) |
0.00307 (0.934) |
0.0276 (1.00) |
1 (1.00) |
Del Peak 12(7q11 22) | 20 (5%) | 390 |
0.395 (1.00) |
0.00622 (1.00) |
0.000254 (0.0863) |
1 (1.00) |
0.184 (1.00) |
Del Peak 14(8p23 3) | 62 (15%) | 348 |
0.651 (1.00) |
0.00605 (1.00) |
5.71e-22 (2.5e-19) |
0.659 (1.00) |
0.0065 (1.00) |
Del Peak 15(8p11 22) | 31 (8%) | 379 |
0.521 (1.00) |
0.00108 (0.347) |
1.69e-12 (7.04e-10) |
0.842 (1.00) |
0.033 (1.00) |
Del Peak 38(18q23) | 50 (12%) | 360 |
0.075 (1.00) |
0.00342 (1.00) |
1.14e-07 (4.42e-05) |
0.0238 (1.00) |
0.729 (1.00) |
Del Peak 40(19q13 43) | 28 (7%) | 382 |
0.00916 (1.00) |
0.00082 (0.267) |
1.14e-08 (4.53e-06) |
0.677 (1.00) |
0.0405 (1.00) |
Amp Peak 2(1p22 3) | 53 (13%) | 357 |
0.878 (1.00) |
0.224 (1.00) |
0.271 (1.00) |
0.753 (1.00) |
0.5 (1.00) |
Amp Peak 13(6q16 3) | 32 (8%) | 378 |
0.414 (1.00) |
0.0885 (1.00) |
0.00179 (0.563) |
0.697 (1.00) |
0.289 (1.00) |
Amp Peak 14(7q22 1) | 47 (11%) | 363 |
0.00425 (1.00) |
0.226 (1.00) |
0.0861 (1.00) |
0.0998 (1.00) |
0.374 (1.00) |
Amp Peak 15(8p11 22) | 79 (19%) | 331 |
0.00323 (0.974) |
0.148 (1.00) |
0.506 (1.00) |
0.789 (1.00) |
0.391 (1.00) |
Amp Peak 21(10q22 2) | 96 (23%) | 314 |
0.344 (1.00) |
0.437 (1.00) |
0.128 (1.00) |
1 (1.00) |
0.504 (1.00) |
Amp Peak 25(12p13 33) | 43 (10%) | 367 |
0.394 (1.00) |
0.405 (1.00) |
0.0024 (0.736) |
1 (1.00) |
0.14 (1.00) |
Amp Peak 26(12q13 11) | 46 (11%) | 364 |
0.543 (1.00) |
0.348 (1.00) |
0.00181 (0.565) |
1 (1.00) |
0.595 (1.00) |
Amp Peak 30(15q26 3) | 17 (4%) | 393 |
0.786 (1.00) |
0.411 (1.00) |
0.18 (1.00) |
0.108 (1.00) |
0.153 (1.00) |
Del Peak 4(2q37 3) | 24 (6%) | 386 |
0.668 (1.00) |
0.00726 (1.00) |
0.119 (1.00) |
0.826 (1.00) |
0.224 (1.00) |
Del Peak 10(6q26) | 24 (6%) | 386 |
0.555 (1.00) |
0.0906 (1.00) |
0.000876 (0.284) |
0.652 (1.00) |
1 (1.00) |
Del Peak 18(10q21 2) | 17 (4%) | 393 |
0.776 (1.00) |
0.347 (1.00) |
0.0274 (1.00) |
0.793 (1.00) |
0.392 (1.00) |
Del Peak 19(10q23 31) | 36 (9%) | 374 |
0.414 (1.00) |
0.188 (1.00) |
0.121 (1.00) |
0.133 (1.00) |
0.315 (1.00) |
Del Peak 23(12q23 1) | 19 (5%) | 391 |
0.589 (1.00) |
0.0495 (1.00) |
0.0223 (1.00) |
0.802 (1.00) |
0.279 (1.00) |
Del Peak 26(13q14 2) | 45 (11%) | 365 |
0.376 (1.00) |
0.00277 (0.849) |
0.0138 (1.00) |
0.31 (1.00) |
1 (1.00) |
Del Peak 41(20p12 1) | 19 (5%) | 391 |
0.537 (1.00) |
0.0078 (1.00) |
0.155 (1.00) |
1 (1.00) |
1 (1.00) |
Del Peak 42(20q13 12) | 6 (1%) | 404 |
0.536 (1.00) |
0.0517 (1.00) |
0.654 (1.00) |
0.0855 (1.00) |
1 (1.00) |
Del Peak 43(22q11 1) | 41 (10%) | 369 |
0.787 (1.00) |
0.00225 (0.697) |
0.0748 (1.00) |
0.296 (1.00) |
0.346 (1.00) |
Del Peak 44(22q12 1) | 51 (12%) | 359 |
0.475 (1.00) |
0.0173 (1.00) |
0.0254 (1.00) |
0.2 (1.00) |
0.171 (1.00) |
P value = 1.09e-08 (Chi-square test), Q value = 4.3e-06
Table S1. Gene #1: 'Amp Peak 1(1p34.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 1(1P34.2) MUTATED | 7 | 0 | 0 | 0 | 0 | 3 | 16 |
AMP PEAK 1(1P34.2) WILD-TYPE | 299 | 3 | 8 | 2 | 7 | 14 | 51 |
Figure S1. Get High-res Image Gene #1: 'Amp Peak 1(1p34.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D1V3.png)
P value = 0.000375 (t-test), Q value = 0.13
Table S2. Gene #3: 'Amp Peak 3(1q21.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 3(1Q21.3) MUTATED | 160 | 65.8 (10.3) |
AMP PEAK 3(1Q21.3) WILD-TYPE | 249 | 61.9 (11.3) |
Figure S2. Get High-res Image Gene #3: 'Amp Peak 3(1q21.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D3V2.png)
P value = 3.1e-05 (t-test), Q value = 0.011
Table S3. Gene #4: 'Amp Peak 4(1q22) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 4(1Q22) MUTATED | 170 | 66.1 (10.4) |
AMP PEAK 4(1Q22) WILD-TYPE | 239 | 61.5 (11.2) |
Figure S3. Get High-res Image Gene #4: 'Amp Peak 4(1q22) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D4V2.png)
P value = 2.63e-07 (Chi-square test), Q value = 1e-04
Table S4. Gene #5: 'Amp Peak 5(2p23.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 5(2P23.2) MUTATED | 37 | 0 | 0 | 1 | 1 | 4 | 29 |
AMP PEAK 5(2P23.2) WILD-TYPE | 269 | 3 | 8 | 1 | 6 | 13 | 38 |
Figure S4. Get High-res Image Gene #5: 'Amp Peak 5(2p23.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D5V3.png)
P value = 4.69e-08 (Chi-square test), Q value = 1.8e-05
Table S5. Gene #6: 'Amp Peak 6(2q13) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 6(2Q13) MUTATED | 33 | 0 | 0 | 1 | 0 | 4 | 28 |
AMP PEAK 6(2Q13) WILD-TYPE | 273 | 3 | 8 | 1 | 7 | 13 | 39 |
Figure S5. Get High-res Image Gene #6: 'Amp Peak 6(2q13) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D6V3.png)
P value = 0.000573 (t-test), Q value = 0.19
Table S6. Gene #7: 'Amp Peak 7(3p25.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 7(3P25.1) MUTATED | 48 | 68.9 (11.2) |
AMP PEAK 7(3P25.1) WILD-TYPE | 361 | 62.7 (10.9) |
Figure S6. Get High-res Image Gene #7: 'Amp Peak 7(3p25.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D7V2.png)
P value = 3.33e-07 (Chi-square test), Q value = 0.00013
Table S7. Gene #7: 'Amp Peak 7(3p25.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 7(3P25.1) MUTATED | 23 | 0 | 0 | 0 | 1 | 1 | 23 |
AMP PEAK 7(3P25.1) WILD-TYPE | 283 | 3 | 8 | 2 | 6 | 16 | 44 |
Figure S7. Get High-res Image Gene #7: 'Amp Peak 7(3p25.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D7V3.png)
P value = 1.47e-07 (t-test), Q value = 5.7e-05
Table S8. Gene #8: 'Amp Peak 8(3q26.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 8(3Q26.2) MUTATED | 100 | 68.2 (9.9) |
AMP PEAK 8(3Q26.2) WILD-TYPE | 309 | 61.9 (11.1) |
Figure S8. Get High-res Image Gene #8: 'Amp Peak 8(3q26.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D8V2.png)
P value = 2.64e-18 (Chi-square test), Q value = 1.1e-15
Table S9. Gene #8: 'Amp Peak 8(3q26.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 8(3Q26.2) MUTATED | 46 | 0 | 0 | 0 | 2 | 5 | 47 |
AMP PEAK 8(3Q26.2) WILD-TYPE | 260 | 3 | 8 | 2 | 5 | 12 | 20 |
Figure S9. Get High-res Image Gene #8: 'Amp Peak 8(3q26.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D8V3.png)
P value = 3.75e-05 (t-test), Q value = 0.013
Table S10. Gene #9: 'Amp Peak 9(3q26.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 9(3Q26.2) MUTATED | 95 | 67.3 (9.9) |
AMP PEAK 9(3Q26.2) WILD-TYPE | 314 | 62.2 (11.2) |
Figure S10. Get High-res Image Gene #9: 'Amp Peak 9(3q26.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D9V2.png)
P value = 7.9e-19 (Chi-square test), Q value = 3.4e-16
Table S11. Gene #9: 'Amp Peak 9(3q26.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 9(3Q26.2) MUTATED | 42 | 0 | 0 | 0 | 2 | 5 | 46 |
AMP PEAK 9(3Q26.2) WILD-TYPE | 264 | 3 | 8 | 2 | 5 | 12 | 21 |
Figure S11. Get High-res Image Gene #9: 'Amp Peak 9(3q26.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D9V3.png)
P value = 6.99e-06 (t-test), Q value = 0.0025
Table S12. Gene #10: 'Amp Peak 10(4p16.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 10(4P16.3) MUTATED | 27 | 71.4 (7.8) |
AMP PEAK 10(4P16.3) WILD-TYPE | 382 | 62.9 (11.1) |
Figure S12. Get High-res Image Gene #10: 'Amp Peak 10(4p16.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D10V2.png)
P value = 2.53e-13 (Chi-square test), Q value = 1.1e-10
Table S13. Gene #10: 'Amp Peak 10(4p16.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 10(4P16.3) MUTATED | 6 | 0 | 0 | 0 | 0 | 1 | 20 |
AMP PEAK 10(4P16.3) WILD-TYPE | 300 | 3 | 8 | 2 | 7 | 16 | 47 |
Figure S13. Get High-res Image Gene #10: 'Amp Peak 10(4p16.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D10V3.png)
P value = 6.55e-12 (Chi-square test), Q value = 2.7e-09
Table S14. Gene #11: 'Amp Peak 11(5p15.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 11(5P15.33) MUTATED | 20 | 0 | 0 | 0 | 0 | 1 | 27 |
AMP PEAK 11(5P15.33) WILD-TYPE | 286 | 3 | 8 | 2 | 7 | 16 | 40 |
Figure S14. Get High-res Image Gene #11: 'Amp Peak 11(5p15.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D11V3.png)
P value = 0.000327 (t-test), Q value = 0.11
Table S15. Gene #12: 'Amp Peak 12(6p24.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 12(6P24.2) MUTATED | 58 | 68.2 (10.3) |
AMP PEAK 12(6P24.2) WILD-TYPE | 351 | 62.6 (11.1) |
Figure S15. Get High-res Image Gene #12: 'Amp Peak 12(6p24.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D12V2.png)
P value = 1.53e-10 (Chi-square test), Q value = 6.3e-08
Table S16. Gene #12: 'Amp Peak 12(6p24.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 12(6P24.2) MUTATED | 28 | 0 | 0 | 0 | 0 | 1 | 29 |
AMP PEAK 12(6P24.2) WILD-TYPE | 278 | 3 | 8 | 2 | 7 | 16 | 38 |
Figure S16. Get High-res Image Gene #12: 'Amp Peak 12(6p24.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D12V3.png)
P value = 4.98e-06 (logrank test), Q value = 0.0018
Table S17. Gene #16: 'Amp Peak 16(8p11.21) mutation analysis' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 407 | 40 | 0.0 - 187.1 (17.2) |
AMP PEAK 16(8P11.21) MUTATED | 98 | 20 | 0.5 - 113.2 (12.5) |
AMP PEAK 16(8P11.21) WILD-TYPE | 309 | 20 | 0.0 - 187.1 (18.1) |
Figure S17. Get High-res Image Gene #16: 'Amp Peak 16(8p11.21) mutation analysis' versus Clinical Feature #1: 'Time to Death'
![](D16V1.png)
P value = 0.000563 (Chi-square test), Q value = 0.19
Table S18. Gene #16: 'Amp Peak 16(8p11.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 16(8P11.21) MUTATED | 60 | 1 | 0 | 0 | 3 | 4 | 30 |
AMP PEAK 16(8P11.21) WILD-TYPE | 246 | 2 | 8 | 2 | 4 | 13 | 37 |
Figure S18. Get High-res Image Gene #16: 'Amp Peak 16(8p11.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D16V3.png)
P value = 0.000637 (logrank test), Q value = 0.21
Table S19. Gene #17: 'Amp Peak 17(8q24.21) mutation analysis' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 407 | 40 | 0.0 - 187.1 (17.2) |
AMP PEAK 17(8Q24.21) MUTATED | 124 | 21 | 0.1 - 187.1 (13.8) |
AMP PEAK 17(8Q24.21) WILD-TYPE | 283 | 19 | 0.0 - 173.6 (17.9) |
Figure S19. Get High-res Image Gene #17: 'Amp Peak 17(8q24.21) mutation analysis' versus Clinical Feature #1: 'Time to Death'
![](D17V1.png)
P value = 1.2e-08 (Chi-square test), Q value = 4.8e-06
Table S20. Gene #17: 'Amp Peak 17(8q24.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 17(8Q24.21) MUTATED | 72 | 1 | 0 | 0 | 3 | 6 | 43 |
AMP PEAK 17(8Q24.21) WILD-TYPE | 234 | 2 | 8 | 2 | 4 | 11 | 24 |
Figure S20. Get High-res Image Gene #17: 'Amp Peak 17(8q24.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D17V3.png)
P value = 1.22e-09 (Chi-square test), Q value = 4.9e-07
Table S21. Gene #18: 'Amp Peak 18(8q24.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 18(8Q24.21) MUTATED | 77 | 1 | 0 | 0 | 3 | 5 | 46 |
AMP PEAK 18(8Q24.21) WILD-TYPE | 229 | 2 | 8 | 2 | 4 | 12 | 21 |
Figure S21. Get High-res Image Gene #18: 'Amp Peak 18(8q24.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D18V3.png)
P value = 7.7e-06 (Chi-square test), Q value = 0.0028
Table S22. Gene #19: 'Amp Peak 19(9p24.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 19(9P24.2) MUTATED | 16 | 0 | 0 | 0 | 0 | 0 | 17 |
AMP PEAK 19(9P24.2) WILD-TYPE | 290 | 3 | 8 | 2 | 7 | 17 | 50 |
Figure S22. Get High-res Image Gene #19: 'Amp Peak 19(9p24.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D19V3.png)
P value = 9.12e-07 (Chi-square test), Q value = 0.00034
Table S23. Gene #20: 'Amp Peak 20(9q34.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 20(9Q34.3) MUTATED | 5 | 0 | 0 | 0 | 0 | 3 | 12 |
AMP PEAK 20(9Q34.3) WILD-TYPE | 301 | 3 | 8 | 2 | 7 | 14 | 55 |
Figure S23. Get High-res Image Gene #20: 'Amp Peak 20(9q34.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D20V3.png)
P value = 0.000598 (t-test), Q value = 0.2
Table S24. Gene #22: 'Amp Peak 22(11p11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 22(11P11.2) MUTATED | 23 | 71.3 (9.9) |
AMP PEAK 22(11P11.2) WILD-TYPE | 386 | 62.9 (11.0) |
Figure S24. Get High-res Image Gene #22: 'Amp Peak 22(11p11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D22V2.png)
P value = 3.37e-08 (Chi-square test), Q value = 1.3e-05
Table S25. Gene #22: 'Amp Peak 22(11p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 22(11P11.2) MUTATED | 6 | 0 | 0 | 0 | 0 | 2 | 15 |
AMP PEAK 22(11P11.2) WILD-TYPE | 300 | 3 | 8 | 2 | 7 | 15 | 52 |
Figure S25. Get High-res Image Gene #22: 'Amp Peak 22(11p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D22V3.png)
P value = 0.000101 (Chi-square test), Q value = 0.035
Table S26. Gene #23: 'Amp Peak 23(11q13.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 23(11Q13.2) MUTATED | 16 | 0 | 0 | 0 | 0 | 1 | 16 |
AMP PEAK 23(11Q13.2) WILD-TYPE | 290 | 3 | 8 | 2 | 7 | 16 | 51 |
Figure S26. Get High-res Image Gene #23: 'Amp Peak 23(11q13.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D23V3.png)
P value = 9.74e-05 (Chi-square test), Q value = 0.034
Table S27. Gene #24: 'Amp Peak 24(11q22.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 24(11Q22.2) MUTATED | 9 | 0 | 0 | 0 | 0 | 3 | 12 |
AMP PEAK 24(11Q22.2) WILD-TYPE | 297 | 3 | 8 | 2 | 7 | 14 | 55 |
Figure S27. Get High-res Image Gene #24: 'Amp Peak 24(11q22.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D24V3.png)
P value = 9.11e-06 (Chi-square test), Q value = 0.0033
Table S28. Gene #27: 'Amp Peak 27(12q13.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 27(12Q13.2) MUTATED | 27 | 0 | 0 | 0 | 0 | 1 | 22 |
AMP PEAK 27(12Q13.2) WILD-TYPE | 279 | 3 | 8 | 2 | 7 | 16 | 45 |
Figure S28. Get High-res Image Gene #27: 'Amp Peak 27(12q13.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D27V3.png)
P value = 3.57e-07 (Chi-square test), Q value = 0.00014
Table S29. Gene #28: 'Amp Peak 28(14q24.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 28(14Q24.3) MUTATED | 11 | 0 | 0 | 0 | 0 | 2 | 17 |
AMP PEAK 28(14Q24.3) WILD-TYPE | 295 | 3 | 8 | 2 | 7 | 15 | 50 |
Figure S29. Get High-res Image Gene #28: 'Amp Peak 28(14q24.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D28V3.png)
P value = 1.51e-06 (Chi-square test), Q value = 0.00056
Table S30. Gene #29: 'Amp Peak 29(14q32.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 29(14Q32.33) MUTATED | 14 | 0 | 0 | 0 | 0 | 0 | 17 |
AMP PEAK 29(14Q32.33) WILD-TYPE | 292 | 3 | 8 | 2 | 7 | 17 | 50 |
Figure S30. Get High-res Image Gene #29: 'Amp Peak 29(14q32.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D29V3.png)
P value = 1.63e-14 (Chi-square test), Q value = 6.9e-12
Table S31. Gene #31: 'Amp Peak 31(16p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 31(16P11.2) MUTATED | 8 | 0 | 0 | 0 | 0 | 2 | 23 |
AMP PEAK 31(16P11.2) WILD-TYPE | 298 | 3 | 8 | 2 | 7 | 15 | 44 |
Figure S31. Get High-res Image Gene #31: 'Amp Peak 31(16p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D31V3.png)
P value = 0.000398 (Chi-square test), Q value = 0.13
Table S32. Gene #32: 'Amp Peak 32(17p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 32(17P11.2) MUTATED | 5 | 0 | 0 | 0 | 0 | 0 | 9 |
AMP PEAK 32(17P11.2) WILD-TYPE | 301 | 3 | 8 | 2 | 7 | 17 | 58 |
Figure S32. Get High-res Image Gene #32: 'Amp Peak 32(17p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D32V3.png)
P value = 6.25e-11 (Chi-square test), Q value = 2.6e-08
Table S33. Gene #33: 'Amp Peak 33(17q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 33(17Q11.2) MUTATED | 10 | 0 | 0 | 0 | 1 | 5 | 20 |
AMP PEAK 33(17Q11.2) WILD-TYPE | 296 | 3 | 8 | 2 | 6 | 12 | 47 |
Figure S33. Get High-res Image Gene #33: 'Amp Peak 33(17q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D33V3.png)
P value = 4.53e-05 (t-test), Q value = 0.016
Table S34. Gene #34: 'Amp Peak 34(17q12) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 34(17Q12) MUTATED | 46 | 69.2 (9.3) |
AMP PEAK 34(17Q12) WILD-TYPE | 363 | 62.7 (11.1) |
Figure S34. Get High-res Image Gene #34: 'Amp Peak 34(17q12) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D34V2.png)
P value = 1.44e-15 (Chi-square test), Q value = 6.1e-13
Table S35. Gene #34: 'Amp Peak 34(17q12) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 34(17Q12) MUTATED | 13 | 0 | 1 | 0 | 0 | 4 | 28 |
AMP PEAK 34(17Q12) WILD-TYPE | 293 | 3 | 7 | 2 | 7 | 13 | 39 |
Figure S35. Get High-res Image Gene #34: 'Amp Peak 34(17q12) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D34V3.png)
P value = 2.52e-05 (t-test), Q value = 0.009
Table S36. Gene #35: 'Amp Peak 35(17q21.32) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 35(17Q21.32) MUTATED | 36 | 70.0 (8.6) |
AMP PEAK 35(17Q21.32) WILD-TYPE | 373 | 62.8 (11.1) |
Figure S36. Get High-res Image Gene #35: 'Amp Peak 35(17q21.32) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D35V2.png)
P value = 3.74e-06 (Chi-square test), Q value = 0.0014
Table S37. Gene #35: 'Amp Peak 35(17q21.32) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 35(17Q21.32) MUTATED | 15 | 0 | 0 | 0 | 0 | 4 | 17 |
AMP PEAK 35(17Q21.32) WILD-TYPE | 291 | 3 | 8 | 2 | 7 | 13 | 50 |
Figure S37. Get High-res Image Gene #35: 'Amp Peak 35(17q21.32) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D35V3.png)
P value = 2.49e-08 (Chi-square test), Q value = 9.8e-06
Table S38. Gene #36: 'Amp Peak 36(18q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 36(18Q11.2) MUTATED | 10 | 0 | 0 | 0 | 1 | 3 | 18 |
AMP PEAK 36(18Q11.2) WILD-TYPE | 296 | 3 | 8 | 2 | 6 | 14 | 49 |
Figure S38. Get High-res Image Gene #36: 'Amp Peak 36(18q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D36V3.png)
P value = 2.3e-10 (t-test), Q value = 9.3e-08
Table S39. Gene #37: 'Amp Peak 37(19p13.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 37(19P13.2) MUTATED | 49 | 71.7 (8.0) |
AMP PEAK 37(19P13.2) WILD-TYPE | 360 | 62.3 (11.0) |
Figure S39. Get High-res Image Gene #37: 'Amp Peak 37(19p13.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D37V2.png)
P value = 8.1e-16 (Chi-square test), Q value = 3.4e-13
Table S40. Gene #37: 'Amp Peak 37(19p13.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 37(19P13.2) MUTATED | 14 | 0 | 0 | 0 | 1 | 6 | 28 |
AMP PEAK 37(19P13.2) WILD-TYPE | 292 | 3 | 8 | 2 | 6 | 11 | 39 |
Figure S40. Get High-res Image Gene #37: 'Amp Peak 37(19p13.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D37V3.png)
P value = 4.88e-11 (t-test), Q value = 2e-08
Table S41. Gene #38: 'Amp Peak 38(19p13.13) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 38(19P13.13) MUTATED | 53 | 71.6 (8.0) |
AMP PEAK 38(19P13.13) WILD-TYPE | 356 | 62.2 (11.0) |
Figure S41. Get High-res Image Gene #38: 'Amp Peak 38(19p13.13) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D38V2.png)
P value = 3.46e-19 (Chi-square test), Q value = 1.5e-16
Table S42. Gene #38: 'Amp Peak 38(19p13.13) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 38(19P13.13) MUTATED | 16 | 0 | 0 | 0 | 0 | 4 | 33 |
AMP PEAK 38(19P13.13) WILD-TYPE | 290 | 3 | 8 | 2 | 7 | 13 | 34 |
Figure S42. Get High-res Image Gene #38: 'Amp Peak 38(19p13.13) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D38V3.png)
P value = 8.84e-07 (t-test), Q value = 0.00033
Table S43. Gene #39: 'Amp Peak 39(19q12) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 39(19Q12) MUTATED | 49 | 68.9 (7.1) |
AMP PEAK 39(19Q12) WILD-TYPE | 360 | 62.7 (11.4) |
Figure S43. Get High-res Image Gene #39: 'Amp Peak 39(19q12) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D39V2.png)
P value = 6.08e-24 (Chi-square test), Q value = 2.7e-21
Table S44. Gene #39: 'Amp Peak 39(19q12) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 39(19Q12) MUTATED | 10 | 0 | 0 | 0 | 0 | 6 | 33 |
AMP PEAK 39(19Q12) WILD-TYPE | 296 | 3 | 8 | 2 | 7 | 11 | 34 |
Figure S44. Get High-res Image Gene #39: 'Amp Peak 39(19q12) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D39V3.png)
P value = 3.68e-05 (Fisher's exact test), Q value = 0.013
Table S45. Gene #39: 'Amp Peak 39(19q12) mutation analysis' versus Clinical Feature #5: 'NEOADJUVANT.THERAPY'
nPatients | NO | YES |
---|---|---|
ALL | 306 | 104 |
AMP PEAK 39(19Q12) MUTATED | 24 | 25 |
AMP PEAK 39(19Q12) WILD-TYPE | 282 | 79 |
Figure S45. Get High-res Image Gene #39: 'Amp Peak 39(19q12) mutation analysis' versus Clinical Feature #5: 'NEOADJUVANT.THERAPY'
![](D39V5.png)
P value = 2.24e-06 (Chi-square test), Q value = 0.00083
Table S46. Gene #40: 'Amp Peak 40(20p13) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 40(20P13) MUTATED | 25 | 0 | 0 | 1 | 0 | 2 | 22 |
AMP PEAK 40(20P13) WILD-TYPE | 281 | 3 | 8 | 1 | 7 | 15 | 45 |
Figure S46. Get High-res Image Gene #40: 'Amp Peak 40(20p13) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D40V3.png)
P value = 0.000187 (t-test), Q value = 0.064
Table S47. Gene #41: 'Amp Peak 41(20q11.21) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 41(20Q11.21) MUTATED | 65 | 67.6 (9.1) |
AMP PEAK 41(20Q11.21) WILD-TYPE | 344 | 62.6 (11.3) |
Figure S47. Get High-res Image Gene #41: 'Amp Peak 41(20q11.21) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D41V2.png)
P value = 7.37e-20 (Chi-square test), Q value = 3.2e-17
Table S48. Gene #41: 'Amp Peak 41(20q11.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 41(20Q11.21) MUTATED | 22 | 0 | 0 | 1 | 0 | 5 | 37 |
AMP PEAK 41(20Q11.21) WILD-TYPE | 284 | 3 | 8 | 1 | 7 | 12 | 30 |
Figure S48. Get High-res Image Gene #41: 'Amp Peak 41(20q11.21) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D41V3.png)
P value = 7.44e-05 (t-test), Q value = 0.026
Table S49. Gene #42: 'Amp Peak 42(20q13.12) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 42(20Q13.12) MUTATED | 67 | 68.2 (10.1) |
AMP PEAK 42(20Q13.12) WILD-TYPE | 342 | 62.5 (11.1) |
Figure S49. Get High-res Image Gene #42: 'Amp Peak 42(20q13.12) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D42V2.png)
P value = 3.15e-18 (Chi-square test), Q value = 1.4e-15
Table S50. Gene #42: 'Amp Peak 42(20q13.12) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 42(20Q13.12) MUTATED | 24 | 0 | 0 | 1 | 1 | 4 | 37 |
AMP PEAK 42(20Q13.12) WILD-TYPE | 282 | 3 | 8 | 1 | 6 | 13 | 30 |
Figure S50. Get High-res Image Gene #42: 'Amp Peak 42(20q13.12) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D42V3.png)
P value = 0.000195 (t-test), Q value = 0.067
Table S51. Gene #43: 'Amp Peak 43(20q13.33) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
AMP PEAK 43(20Q13.33) MUTATED | 68 | 67.8 (10.2) |
AMP PEAK 43(20Q13.33) WILD-TYPE | 341 | 62.5 (11.1) |
Figure S51. Get High-res Image Gene #43: 'Amp Peak 43(20q13.33) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D43V2.png)
P value = 1.95e-11 (Chi-square test), Q value = 8.1e-09
Table S52. Gene #43: 'Amp Peak 43(20q13.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
AMP PEAK 43(20Q13.33) MUTATED | 30 | 0 | 0 | 1 | 2 | 3 | 32 |
AMP PEAK 43(20Q13.33) WILD-TYPE | 276 | 3 | 8 | 1 | 5 | 14 | 35 |
Figure S52. Get High-res Image Gene #43: 'Amp Peak 43(20q13.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D43V3.png)
P value = 0.000403 (Chi-square test), Q value = 0.13
Table S53. Gene #44: 'Del Peak 1(1p36.31) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 1(1P36.31) MUTATED | 20 | 0 | 0 | 0 | 0 | 4 | 16 |
DEL PEAK 1(1P36.31) WILD-TYPE | 286 | 3 | 8 | 2 | 7 | 13 | 51 |
Figure S53. Get High-res Image Gene #44: 'Del Peak 1(1p36.31) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D44V3.png)
P value = 0.000629 (t-test), Q value = 0.21
Table S54. Gene #45: 'Del Peak 2(1p36.11) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 2(1P36.11) MUTATED | 46 | 68.1 (9.2) |
DEL PEAK 2(1P36.11) WILD-TYPE | 363 | 62.8 (11.2) |
Figure S54. Get High-res Image Gene #45: 'Del Peak 2(1p36.11) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D45V2.png)
P value = 5.65e-10 (Chi-square test), Q value = 2.3e-07
Table S55. Gene #45: 'Del Peak 2(1p36.11) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 2(1P36.11) MUTATED | 18 | 0 | 0 | 0 | 0 | 4 | 24 |
DEL PEAK 2(1P36.11) WILD-TYPE | 288 | 3 | 8 | 2 | 7 | 13 | 43 |
Figure S55. Get High-res Image Gene #45: 'Del Peak 2(1p36.11) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D45V3.png)
P value = 3.39e-05 (logrank test), Q value = 0.012
Table S56. Gene #46: 'Del Peak 3(2q22.1) mutation analysis' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 407 | 40 | 0.0 - 187.1 (17.2) |
DEL PEAK 3(2Q22.1) MUTATED | 26 | 7 | 0.5 - 113.2 (8.3) |
DEL PEAK 3(2Q22.1) WILD-TYPE | 381 | 33 | 0.0 - 187.1 (18.1) |
Figure S56. Get High-res Image Gene #46: 'Del Peak 3(2q22.1) mutation analysis' versus Clinical Feature #1: 'Time to Death'
![](D46V1.png)
P value = 2.97e-05 (t-test), Q value = 0.011
Table S57. Gene #48: 'Del Peak 5(3p14.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 5(3P14.2) MUTATED | 40 | 68.7 (7.4) |
DEL PEAK 5(3P14.2) WILD-TYPE | 369 | 62.8 (11.3) |
Figure S57. Get High-res Image Gene #48: 'Del Peak 5(3p14.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D48V2.png)
P value = 4.56e-10 (Chi-square test), Q value = 1.8e-07
Table S58. Gene #48: 'Del Peak 5(3p14.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 5(3P14.2) MUTATED | 13 | 0 | 0 | 0 | 1 | 5 | 21 |
DEL PEAK 5(3P14.2) WILD-TYPE | 293 | 3 | 8 | 2 | 6 | 12 | 46 |
Figure S58. Get High-res Image Gene #48: 'Del Peak 5(3p14.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D48V3.png)
P value = 0.000132 (t-test), Q value = 0.045
Table S59. Gene #49: 'Del Peak 6(4p16.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 6(4P16.3) MUTATED | 45 | 68.4 (8.3) |
DEL PEAK 6(4P16.3) WILD-TYPE | 364 | 62.8 (11.3) |
Figure S59. Get High-res Image Gene #49: 'Del Peak 6(4p16.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D49V2.png)
P value = 3.8e-11 (Chi-square test), Q value = 1.6e-08
Table S60. Gene #49: 'Del Peak 6(4p16.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 6(4P16.3) MUTATED | 16 | 0 | 0 | 0 | 1 | 3 | 25 |
DEL PEAK 6(4P16.3) WILD-TYPE | 290 | 3 | 8 | 2 | 6 | 14 | 42 |
Figure S60. Get High-res Image Gene #49: 'Del Peak 6(4p16.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D49V3.png)
P value = 0.000763 (t-test), Q value = 0.25
Table S61. Gene #50: 'Del Peak 7(4q22.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 7(4Q22.1) MUTATED | 46 | 68.1 (9.3) |
DEL PEAK 7(4Q22.1) WILD-TYPE | 363 | 62.8 (11.2) |
Figure S61. Get High-res Image Gene #50: 'Del Peak 7(4q22.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D50V2.png)
P value = 1.18e-12 (Chi-square test), Q value = 5e-10
Table S62. Gene #50: 'Del Peak 7(4q22.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 7(4Q22.1) MUTATED | 15 | 0 | 0 | 0 | 1 | 4 | 26 |
DEL PEAK 7(4Q22.1) WILD-TYPE | 291 | 3 | 8 | 2 | 6 | 13 | 41 |
Figure S62. Get High-res Image Gene #50: 'Del Peak 7(4q22.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D50V3.png)
P value = 6.48e-05 (t-test), Q value = 0.023
Table S63. Gene #51: 'Del Peak 8(4q34.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 8(4Q34.3) MUTATED | 63 | 67.9 (8.8) |
DEL PEAK 8(4Q34.3) WILD-TYPE | 346 | 62.6 (11.3) |
Figure S63. Get High-res Image Gene #51: 'Del Peak 8(4q34.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D51V2.png)
P value = 3.04e-17 (Chi-square test), Q value = 1.3e-14
Table S64. Gene #51: 'Del Peak 8(4q34.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 8(4Q34.3) MUTATED | 21 | 0 | 0 | 0 | 2 | 6 | 34 |
DEL PEAK 8(4Q34.3) WILD-TYPE | 285 | 3 | 8 | 2 | 5 | 11 | 33 |
Figure S64. Get High-res Image Gene #51: 'Del Peak 8(4q34.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D51V3.png)
P value = 7.98e-05 (t-test), Q value = 0.028
Table S65. Gene #52: 'Del Peak 9(5q11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 9(5Q11.2) MUTATED | 53 | 68.2 (8.5) |
DEL PEAK 9(5Q11.2) WILD-TYPE | 356 | 62.7 (11.3) |
Figure S65. Get High-res Image Gene #52: 'Del Peak 9(5q11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D52V2.png)
P value = 1.13e-21 (Chi-square test), Q value = 4.9e-19
Table S66. Gene #52: 'Del Peak 9(5q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 9(5Q11.2) MUTATED | 17 | 0 | 0 | 0 | 1 | 0 | 35 |
DEL PEAK 9(5Q11.2) WILD-TYPE | 289 | 3 | 8 | 2 | 6 | 17 | 32 |
Figure S66. Get High-res Image Gene #52: 'Del Peak 9(5q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D52V3.png)
P value = 0.000118 (t-test), Q value = 0.041
Table S67. Gene #54: 'Del Peak 11(7p22.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 11(7P22.3) MUTATED | 43 | 69.3 (9.8) |
DEL PEAK 11(7P22.3) WILD-TYPE | 366 | 62.7 (11.1) |
Figure S67. Get High-res Image Gene #54: 'Del Peak 11(7p22.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D54V2.png)
P value = 2.65e-10 (Chi-square test), Q value = 1.1e-07
Table S68. Gene #54: 'Del Peak 11(7p22.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 11(7P22.3) MUTATED | 16 | 0 | 0 | 0 | 1 | 3 | 24 |
DEL PEAK 11(7P22.3) WILD-TYPE | 290 | 3 | 8 | 2 | 6 | 14 | 43 |
Figure S68. Get High-res Image Gene #54: 'Del Peak 11(7p22.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D54V3.png)
P value = 0.000254 (Chi-square test), Q value = 0.086
Table S69. Gene #55: 'Del Peak 12(7q11.22) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 12(7Q11.22) MUTATED | 7 | 0 | 0 | 0 | 1 | 1 | 11 |
DEL PEAK 12(7Q11.22) WILD-TYPE | 299 | 3 | 8 | 2 | 6 | 16 | 56 |
Figure S69. Get High-res Image Gene #55: 'Del Peak 12(7q11.22) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D55V3.png)
P value = 1.15e-06 (t-test), Q value = 0.00043
Table S70. Gene #56: 'Del Peak 13(7q36.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 13(7Q36.1) MUTATED | 40 | 70.1 (7.8) |
DEL PEAK 13(7Q36.1) WILD-TYPE | 369 | 62.7 (11.2) |
Figure S70. Get High-res Image Gene #56: 'Del Peak 13(7q36.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D56V2.png)
P value = 6.81e-20 (Chi-square test), Q value = 3e-17
Table S71. Gene #56: 'Del Peak 13(7q36.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 13(7Q36.1) MUTATED | 7 | 0 | 0 | 0 | 1 | 4 | 28 |
DEL PEAK 13(7Q36.1) WILD-TYPE | 299 | 3 | 8 | 2 | 6 | 13 | 39 |
Figure S71. Get High-res Image Gene #56: 'Del Peak 13(7q36.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D56V3.png)
P value = 5.71e-22 (Chi-square test), Q value = 2.5e-19
Table S72. Gene #57: 'Del Peak 14(8p23.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 14(8P23.3) MUTATED | 19 | 0 | 0 | 0 | 2 | 3 | 38 |
DEL PEAK 14(8P23.3) WILD-TYPE | 287 | 3 | 8 | 2 | 5 | 14 | 29 |
Figure S72. Get High-res Image Gene #57: 'Del Peak 14(8p23.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D57V3.png)
P value = 1.69e-12 (Chi-square test), Q value = 7e-10
Table S73. Gene #58: 'Del Peak 15(8p11.22) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 15(8P11.22) MUTATED | 8 | 0 | 0 | 0 | 0 | 2 | 21 |
DEL PEAK 15(8P11.22) WILD-TYPE | 298 | 3 | 8 | 2 | 7 | 15 | 46 |
Figure S73. Get High-res Image Gene #58: 'Del Peak 15(8p11.22) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D58V3.png)
P value = 0.000322 (t-test), Q value = 0.11
Table S74. Gene #59: 'Del Peak 16(9p23) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 16(9P23) MUTATED | 36 | 68.7 (8.3) |
DEL PEAK 16(9P23) WILD-TYPE | 373 | 62.9 (11.2) |
Figure S74. Get High-res Image Gene #59: 'Del Peak 16(9p23) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D59V2.png)
P value = 2.95e-08 (Chi-square test), Q value = 1.2e-05
Table S75. Gene #59: 'Del Peak 16(9p23) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 16(9P23) MUTATED | 14 | 0 | 0 | 0 | 0 | 2 | 20 |
DEL PEAK 16(9P23) WILD-TYPE | 292 | 3 | 8 | 2 | 7 | 15 | 47 |
Figure S75. Get High-res Image Gene #59: 'Del Peak 16(9p23) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D59V3.png)
P value = 2.51e-08 (t-test), Q value = 9.8e-06
Table S76. Gene #60: 'Del Peak 17(9q34.11) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 17(9Q34.11) MUTATED | 75 | 69.1 (8.6) |
DEL PEAK 17(9Q34.11) WILD-TYPE | 334 | 62.2 (11.2) |
Figure S76. Get High-res Image Gene #60: 'Del Peak 17(9q34.11) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D60V2.png)
P value = 1.51e-10 (Chi-square test), Q value = 6.2e-08
Table S77. Gene #60: 'Del Peak 17(9q34.11) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 17(9Q34.11) MUTATED | 35 | 0 | 0 | 0 | 2 | 5 | 33 |
DEL PEAK 17(9Q34.11) WILD-TYPE | 271 | 3 | 8 | 2 | 5 | 12 | 34 |
Figure S77. Get High-res Image Gene #60: 'Del Peak 17(9q34.11) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D60V3.png)
P value = 2.26e-06 (t-test), Q value = 0.00084
Table S78. Gene #63: 'Del Peak 20(11p15.5) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 20(11P15.5) MUTATED | 54 | 69.3 (8.7) |
DEL PEAK 20(11P15.5) WILD-TYPE | 355 | 62.5 (11.2) |
Figure S78. Get High-res Image Gene #63: 'Del Peak 20(11p15.5) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D63V2.png)
P value = 2.63e-12 (Chi-square test), Q value = 1.1e-09
Table S79. Gene #63: 'Del Peak 20(11p15.5) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 20(11P15.5) MUTATED | 21 | 0 | 0 | 0 | 1 | 3 | 29 |
DEL PEAK 20(11P15.5) WILD-TYPE | 285 | 3 | 8 | 2 | 6 | 14 | 38 |
Figure S79. Get High-res Image Gene #63: 'Del Peak 20(11p15.5) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D63V3.png)
P value = 0.00034 (t-test), Q value = 0.11
Table S80. Gene #64: 'Del Peak 21(11q14.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 21(11Q14.1) MUTATED | 38 | 68.7 (8.7) |
DEL PEAK 21(11Q14.1) WILD-TYPE | 371 | 62.9 (11.2) |
Figure S80. Get High-res Image Gene #64: 'Del Peak 21(11q14.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D64V2.png)
P value = 1.63e-08 (Chi-square test), Q value = 6.4e-06
Table S81. Gene #64: 'Del Peak 21(11q14.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 21(11Q14.1) MUTATED | 14 | 0 | 0 | 0 | 0 | 5 | 19 |
DEL PEAK 21(11Q14.1) WILD-TYPE | 292 | 3 | 8 | 2 | 7 | 12 | 48 |
Figure S81. Get High-res Image Gene #64: 'Del Peak 21(11q14.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D64V3.png)
P value = 7.03e-05 (t-test), Q value = 0.025
Table S82. Gene #65: 'Del Peak 22(11q24.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 22(11Q24.2) MUTATED | 48 | 68.5 (8.6) |
DEL PEAK 22(11Q24.2) WILD-TYPE | 361 | 62.7 (11.2) |
Figure S82. Get High-res Image Gene #65: 'Del Peak 22(11q24.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D65V2.png)
P value = 7.84e-09 (Chi-square test), Q value = 3.1e-06
Table S83. Gene #65: 'Del Peak 22(11q24.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 22(11Q24.2) MUTATED | 20 | 0 | 0 | 0 | 0 | 5 | 23 |
DEL PEAK 22(11Q24.2) WILD-TYPE | 286 | 3 | 8 | 2 | 7 | 12 | 44 |
Figure S83. Get High-res Image Gene #65: 'Del Peak 22(11q24.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D65V3.png)
P value = 0.000398 (t-test), Q value = 0.13
Table S84. Gene #67: 'Del Peak 24(12q24.33) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 24(12Q24.33) MUTATED | 26 | 69.5 (7.9) |
DEL PEAK 24(12Q24.33) WILD-TYPE | 383 | 63.0 (11.2) |
Figure S84. Get High-res Image Gene #67: 'Del Peak 24(12q24.33) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D67V2.png)
P value = 3.81e-06 (Chi-square test), Q value = 0.0014
Table S85. Gene #67: 'Del Peak 24(12q24.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 24(12Q24.33) MUTATED | 10 | 0 | 0 | 0 | 0 | 1 | 15 |
DEL PEAK 24(12Q24.33) WILD-TYPE | 296 | 3 | 8 | 2 | 7 | 16 | 52 |
Figure S85. Get High-res Image Gene #67: 'Del Peak 24(12q24.33) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D67V3.png)
P value = 0.000346 (t-test), Q value = 0.12
Table S86. Gene #68: 'Del Peak 25(13q11) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 25(13Q11) MUTATED | 43 | 68.3 (8.7) |
DEL PEAK 25(13Q11) WILD-TYPE | 366 | 62.8 (11.2) |
Figure S86. Get High-res Image Gene #68: 'Del Peak 25(13q11) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D68V2.png)
P value = 2e-06 (Chi-square test), Q value = 0.00074
Table S87. Gene #68: 'Del Peak 25(13q11) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 25(13Q11) MUTATED | 19 | 0 | 0 | 0 | 2 | 2 | 20 |
DEL PEAK 25(13Q11) WILD-TYPE | 287 | 3 | 8 | 2 | 5 | 15 | 47 |
Figure S87. Get High-res Image Gene #68: 'Del Peak 25(13q11) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D68V3.png)
P value = 3.65e-05 (t-test), Q value = 0.013
Table S88. Gene #70: 'Del Peak 27(14q13.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 27(14Q13.1) MUTATED | 34 | 69.7 (8.1) |
DEL PEAK 27(14Q13.1) WILD-TYPE | 375 | 62.8 (11.2) |
Figure S88. Get High-res Image Gene #70: 'Del Peak 27(14q13.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D70V2.png)
P value = 6.3e-07 (Chi-square test), Q value = 0.00024
Table S89. Gene #70: 'Del Peak 27(14q13.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 27(14Q13.1) MUTATED | 13 | 0 | 0 | 0 | 0 | 4 | 17 |
DEL PEAK 27(14Q13.1) WILD-TYPE | 293 | 3 | 8 | 2 | 7 | 13 | 50 |
Figure S89. Get High-res Image Gene #70: 'Del Peak 27(14q13.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D70V3.png)
P value = 1.26e-06 (t-test), Q value = 0.00047
Table S90. Gene #71: 'Del Peak 28(15q15.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 28(15Q15.1) MUTATED | 73 | 68.4 (8.8) |
DEL PEAK 28(15Q15.1) WILD-TYPE | 336 | 62.3 (11.3) |
Figure S90. Get High-res Image Gene #71: 'Del Peak 28(15q15.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D71V2.png)
P value = 1.73e-10 (Chi-square test), Q value = 7.1e-08
Table S91. Gene #71: 'Del Peak 28(15q15.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 28(15Q15.1) MUTATED | 33 | 0 | 0 | 0 | 2 | 7 | 31 |
DEL PEAK 28(15Q15.1) WILD-TYPE | 273 | 3 | 8 | 2 | 5 | 10 | 36 |
Figure S91. Get High-res Image Gene #71: 'Del Peak 28(15q15.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D71V3.png)
P value = 5.07e-06 (t-test), Q value = 0.0018
Table S92. Gene #72: 'Del Peak 29(15q23) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 29(15Q23) MUTATED | 57 | 69.1 (9.2) |
DEL PEAK 29(15Q23) WILD-TYPE | 352 | 62.5 (11.1) |
Figure S92. Get High-res Image Gene #72: 'Del Peak 29(15q23) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D72V2.png)
P value = 1.91e-11 (Chi-square test), Q value = 7.9e-09
Table S93. Gene #72: 'Del Peak 29(15q23) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 29(15Q23) MUTATED | 22 | 0 | 0 | 0 | 2 | 5 | 28 |
DEL PEAK 29(15Q23) WILD-TYPE | 284 | 3 | 8 | 2 | 5 | 12 | 39 |
Figure S93. Get High-res Image Gene #72: 'Del Peak 29(15q23) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D72V3.png)
P value = 9.23e-07 (t-test), Q value = 0.00035
Table S94. Gene #73: 'Del Peak 30(16p13.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 30(16P13.3) MUTATED | 43 | 70.0 (8.0) |
DEL PEAK 30(16P13.3) WILD-TYPE | 366 | 62.7 (11.2) |
Figure S94. Get High-res Image Gene #73: 'Del Peak 30(16p13.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D73V2.png)
P value = 4.01e-07 (Chi-square test), Q value = 0.00015
Table S95. Gene #73: 'Del Peak 30(16p13.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 30(16P13.3) MUTATED | 19 | 0 | 0 | 0 | 0 | 3 | 21 |
DEL PEAK 30(16P13.3) WILD-TYPE | 287 | 3 | 8 | 2 | 7 | 14 | 46 |
Figure S95. Get High-res Image Gene #73: 'Del Peak 30(16p13.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D73V3.png)
P value = 8.7e-08 (t-test), Q value = 3.4e-05
Table S96. Gene #74: 'Del Peak 31(16q22.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 31(16Q22.3) MUTATED | 95 | 67.9 (8.2) |
DEL PEAK 31(16Q22.3) WILD-TYPE | 314 | 62.1 (11.5) |
Figure S96. Get High-res Image Gene #74: 'Del Peak 31(16q22.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D74V2.png)
P value = 3.46e-16 (Chi-square test), Q value = 1.5e-13
Table S97. Gene #74: 'Del Peak 31(16q22.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 31(16Q22.3) MUTATED | 45 | 0 | 0 | 0 | 1 | 5 | 44 |
DEL PEAK 31(16Q22.3) WILD-TYPE | 261 | 3 | 8 | 2 | 6 | 12 | 23 |
Figure S97. Get High-res Image Gene #74: 'Del Peak 31(16q22.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D74V3.png)
P value = 1.27e-08 (t-test), Q value = 5e-06
Table S98. Gene #75: 'Del Peak 32(16q23.1) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 32(16Q23.1) MUTATED | 100 | 68.1 (8.2) |
DEL PEAK 32(16Q23.1) WILD-TYPE | 309 | 61.9 (11.5) |
Figure S98. Get High-res Image Gene #75: 'Del Peak 32(16q23.1) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D75V2.png)
P value = 3.62e-19 (Chi-square test), Q value = 1.6e-16
Table S99. Gene #75: 'Del Peak 32(16q23.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 32(16Q23.1) MUTATED | 47 | 0 | 0 | 0 | 1 | 4 | 48 |
DEL PEAK 32(16Q23.1) WILD-TYPE | 259 | 3 | 8 | 2 | 6 | 13 | 19 |
Figure S99. Get High-res Image Gene #75: 'Del Peak 32(16q23.1) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D75V3.png)
P value = 2.14e-05 (t-test), Q value = 0.0077
Table S100. Gene #76: 'Del Peak 33(17p13.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 33(17P13.3) MUTATED | 61 | 67.8 (7.7) |
DEL PEAK 33(17P13.3) WILD-TYPE | 348 | 62.7 (11.5) |
Figure S100. Get High-res Image Gene #76: 'Del Peak 33(17p13.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D76V2.png)
P value = 1.17e-11 (Chi-square test), Q value = 4.9e-09
Table S101. Gene #76: 'Del Peak 33(17p13.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 33(17P13.3) MUTATED | 24 | 0 | 0 | 0 | 2 | 7 | 28 |
DEL PEAK 33(17P13.3) WILD-TYPE | 282 | 3 | 8 | 2 | 5 | 10 | 39 |
Figure S101. Get High-res Image Gene #76: 'Del Peak 33(17p13.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D76V3.png)
P value = 4.2e-07 (t-test), Q value = 0.00016
Table S102. Gene #77: 'Del Peak 34(17p11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 34(17P11.2) MUTATED | 71 | 68.5 (8.3) |
DEL PEAK 34(17P11.2) WILD-TYPE | 338 | 62.3 (11.3) |
Figure S102. Get High-res Image Gene #77: 'Del Peak 34(17p11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D77V2.png)
P value = 2.8e-22 (Chi-square test), Q value = 1.2e-19
Table S103. Gene #77: 'Del Peak 34(17p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 34(17P11.2) MUTATED | 23 | 0 | 0 | 0 | 1 | 7 | 40 |
DEL PEAK 34(17P11.2) WILD-TYPE | 283 | 3 | 8 | 2 | 6 | 10 | 27 |
Figure S103. Get High-res Image Gene #77: 'Del Peak 34(17p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D77V3.png)
P value = 2.37e-06 (t-test), Q value = 0.00087
Table S104. Gene #78: 'Del Peak 35(17p11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 35(17P11.2) MUTATED | 64 | 68.4 (8.2) |
DEL PEAK 35(17P11.2) WILD-TYPE | 345 | 62.5 (11.3) |
Figure S104. Get High-res Image Gene #78: 'Del Peak 35(17p11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D78V2.png)
P value = 3.33e-14 (Chi-square test), Q value = 1.4e-11
Table S105. Gene #78: 'Del Peak 35(17p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 35(17P11.2) MUTATED | 25 | 0 | 0 | 0 | 1 | 5 | 33 |
DEL PEAK 35(17P11.2) WILD-TYPE | 281 | 3 | 8 | 2 | 6 | 12 | 34 |
Figure S105. Get High-res Image Gene #78: 'Del Peak 35(17p11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D78V3.png)
P value = 1.28e-05 (t-test), Q value = 0.0046
Table S106. Gene #79: 'Del Peak 36(17q11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 36(17Q11.2) MUTATED | 60 | 68.1 (8.0) |
DEL PEAK 36(17Q11.2) WILD-TYPE | 349 | 62.6 (11.4) |
Figure S106. Get High-res Image Gene #79: 'Del Peak 36(17q11.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D79V2.png)
P value = 3.19e-09 (Chi-square test), Q value = 1.3e-06
Table S107. Gene #79: 'Del Peak 36(17q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 36(17Q11.2) MUTATED | 26 | 0 | 0 | 0 | 2 | 5 | 27 |
DEL PEAK 36(17Q11.2) WILD-TYPE | 280 | 3 | 8 | 2 | 5 | 12 | 40 |
Figure S107. Get High-res Image Gene #79: 'Del Peak 36(17q11.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D79V3.png)
P value = 5.37e-06 (t-test), Q value = 0.002
Table S108. Gene #80: 'Del Peak 37(17q21.2) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 37(17Q21.2) MUTATED | 61 | 68.7 (8.9) |
DEL PEAK 37(17Q21.2) WILD-TYPE | 348 | 62.5 (11.2) |
Figure S108. Get High-res Image Gene #80: 'Del Peak 37(17q21.2) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D80V2.png)
P value = 2.87e-10 (Chi-square test), Q value = 1.2e-07
Table S109. Gene #80: 'Del Peak 37(17q21.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 37(17Q21.2) MUTATED | 26 | 0 | 0 | 0 | 1 | 6 | 28 |
DEL PEAK 37(17Q21.2) WILD-TYPE | 280 | 3 | 8 | 2 | 6 | 11 | 39 |
Figure S109. Get High-res Image Gene #80: 'Del Peak 37(17q21.2) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D80V3.png)
P value = 1.14e-07 (Chi-square test), Q value = 4.4e-05
Table S110. Gene #81: 'Del Peak 38(18q23) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 38(18Q23) MUTATED | 21 | 0 | 0 | 0 | 2 | 5 | 22 |
DEL PEAK 38(18Q23) WILD-TYPE | 285 | 3 | 8 | 2 | 5 | 12 | 45 |
Figure S110. Get High-res Image Gene #81: 'Del Peak 38(18q23) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D81V3.png)
P value = 3.14e-13 (t-test), Q value = 1.3e-10
Table S111. Gene #82: 'Del Peak 39(19p13.3) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 39(19P13.3) MUTATED | 95 | 69.6 (8.0) |
DEL PEAK 39(19P13.3) WILD-TYPE | 314 | 61.6 (11.3) |
Figure S111. Get High-res Image Gene #82: 'Del Peak 39(19p13.3) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D82V2.png)
P value = 2.86e-42 (Chi-square test), Q value = 1.3e-39
Table S112. Gene #82: 'Del Peak 39(19p13.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 39(19P13.3) MUTATED | 27 | 0 | 0 | 0 | 1 | 7 | 60 |
DEL PEAK 39(19P13.3) WILD-TYPE | 279 | 3 | 8 | 2 | 6 | 10 | 7 |
Figure S112. Get High-res Image Gene #82: 'Del Peak 39(19p13.3) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D82V3.png)
P value = 1.14e-08 (Chi-square test), Q value = 4.5e-06
Table S113. Gene #83: 'Del Peak 40(19q13.43) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 40(19Q13.43) MUTATED | 8 | 0 | 0 | 0 | 0 | 4 | 16 |
DEL PEAK 40(19Q13.43) WILD-TYPE | 298 | 3 | 8 | 2 | 7 | 13 | 51 |
Figure S113. Get High-res Image Gene #83: 'Del Peak 40(19q13.43) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D83V3.png)
P value = 1.84e-07 (t-test), Q value = 7.1e-05
Table S114. Gene #88: 'Del Peak 45(22q13.32) mutation analysis' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 409 | 63.4 (11.1) |
DEL PEAK 45(22Q13.32) MUTATED | 79 | 68.9 (9.5) |
DEL PEAK 45(22Q13.32) WILD-TYPE | 330 | 62.1 (11.1) |
Figure S114. Get High-res Image Gene #88: 'Del Peak 45(22q13.32) mutation analysis' versus Clinical Feature #2: 'AGE'
![](D88V2.png)
P value = 2.43e-13 (Chi-square test), Q value = 1e-10
Table S115. Gene #88: 'Del Peak 45(22q13.32) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2) | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|---|---|---|---|
ALL | 306 | 3 | 8 | 2 | 7 | 17 | 67 |
DEL PEAK 45(22Q13.32) MUTATED | 36 | 0 | 0 | 0 | 1 | 5 | 37 |
DEL PEAK 45(22Q13.32) WILD-TYPE | 270 | 3 | 8 | 2 | 6 | 12 | 30 |
Figure S115. Get High-res Image Gene #88: 'Del Peak 45(22q13.32) mutation analysis' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'
![](D88V3.png)
-
Copy number data file = All Lesions File (all_lesions.conf_##.txt, where ## is the confidence level). The all lesions file is from GISTIC pipeline and summarizes the results from the GISTIC run. It contains data about the significant regions of amplification and deletion as well as which samples are amplified or deleted in each of these regions. The identified regions are listed down the first column, and the samples are listed across the first row, starting in column 10.
-
Clinical data file = UCEC.clin.merged.picked.txt
-
Number of patients = 410
-
Number of copy number variation regions = 88
-
Number of selected clinical features = 5
-
Exclude regions that fewer than K tumors have alterations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene cnvs were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene cnvs using 't.test' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.